Pharma & Healthcare
Global Medications for Alcohol Use Disorder (AUD) Market Research Report 2026
- Mar 14, 26
- ID: 730287
- Pages: 119
- Figures: 115
- Views: 11
This report delivers a comprehensive overview of the global Medications for Alcohol Use Disorder (AUD) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medications for Alcohol Use Disorder (AUD). The Medications for Alcohol Use Disorder (AUD) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medications for Alcohol Use Disorder (AUD) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medications for Alcohol Use Disorder (AUD) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Alkermes
Merck KGaA
Lundbeck
Alvogen
Mylan
Teva
Sun Pharmaceutical Industries
Zydus Pharmaceuticals
Taj Pharmaceuticals
TAGI Pharma Inc.
Beijing Wellso Pharmaceutical Co
Glenmark Pharmaceuticals
Rusan Pharma Ltd
Segment by Type
Naltrexone
Acamprosate
Disulfiram
Other
Segment by Application
Hospital
Rehabilitation Institutions
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Medications for Alcohol Use Disorder (AUD) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Medications for Alcohol Use Disorder (AUD) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medications for Alcohol Use Disorder (AUD) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Alkermes
Merck KGaA
Lundbeck
Alvogen
Mylan
Teva
Sun Pharmaceutical Industries
Zydus Pharmaceuticals
Taj Pharmaceuticals
TAGI Pharma Inc.
Beijing Wellso Pharmaceutical Co
Glenmark Pharmaceuticals
Rusan Pharma Ltd
Segment by Type
Naltrexone
Acamprosate
Disulfiram
Other
Segment by Application
Hospital
Rehabilitation Institutions
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Medications for Alcohol Use Disorder (AUD) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Naltrexone
1.2.3 Acamprosate
1.2.4 Disulfiram
1.2.5 Other
1.3 Market by Application
1.3.1 Global Medications for Alcohol Use Disorder (AUD) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Rehabilitation Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medications for Alcohol Use Disorder (AUD) Market Perspective (2021–2032)
2.2 Global Medications for Alcohol Use Disorder (AUD) Growth Trends by Region
2.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Medications for Alcohol Use Disorder (AUD) Historic Market Size by Region (2021–2026)
2.2.3 Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (2027–2032)
2.3 Medications for Alcohol Use Disorder (AUD) Market Dynamics
2.3.1 Medications for Alcohol Use Disorder (AUD) Industry Trends
2.3.2 Medications for Alcohol Use Disorder (AUD) Market Drivers
2.3.3 Medications for Alcohol Use Disorder (AUD) Market Challenges
2.3.4 Medications for Alcohol Use Disorder (AUD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medications for Alcohol Use Disorder (AUD) Players by Revenue
3.1.1 Global Top Medications for Alcohol Use Disorder (AUD) Players by Revenue (2021–2026)
3.1.2 Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Players (2021–2026)
3.2 Global Top Medications for Alcohol Use Disorder (AUD) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Medications for Alcohol Use Disorder (AUD) Revenue
3.4 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio
3.4.1 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medications for Alcohol Use Disorder (AUD) Revenue in 2025
3.5 Global Key Players of Medications for Alcohol Use Disorder (AUD) Head Offices and Areas Served
3.6 Global Key Players of Medications for Alcohol Use Disorder (AUD), Products and Applications
3.7 Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Type
4.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Type (2021–2026)
4.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (2027–2032)
5 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Application
5.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Application (2021–2026)
5.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
6.2 North America Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
6.4 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
7.2 Europe Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
7.4 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
8.2 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021–2026)
8.4 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
9.2 Latin America Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
9.4 Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
10.2 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
10.4 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Medications for Alcohol Use Disorder (AUD) Introduction
11.1.4 Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.1.5 Alkermes Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Introduction
11.2.4 Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.2.5 Merck KGaA Recent Development
11.3 Lundbeck
11.3.1 Lundbeck Company Details
11.3.2 Lundbeck Business Overview
11.3.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Introduction
11.3.4 Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.3.5 Lundbeck Recent Development
11.4 Alvogen
11.4.1 Alvogen Company Details
11.4.2 Alvogen Business Overview
11.4.3 Alvogen Medications for Alcohol Use Disorder (AUD) Introduction
11.4.4 Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.4.5 Alvogen Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Medications for Alcohol Use Disorder (AUD) Introduction
11.5.4 Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.5.5 Mylan Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Medications for Alcohol Use Disorder (AUD) Introduction
11.6.4 Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.6.5 Teva Recent Development
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Details
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Introduction
11.7.4 Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.7.5 Sun Pharmaceutical Industries Recent Development
11.8 Zydus Pharmaceuticals
11.8.1 Zydus Pharmaceuticals Company Details
11.8.2 Zydus Pharmaceuticals Business Overview
11.8.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
11.8.4 Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.8.5 Zydus Pharmaceuticals Recent Development
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Details
11.9.2 Taj Pharmaceuticals Business Overview
11.9.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
11.9.4 Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.9.5 Taj Pharmaceuticals Recent Development
11.10 TAGI Pharma Inc.
11.10.1 TAGI Pharma Inc. Company Details
11.10.2 TAGI Pharma Inc. Business Overview
11.10.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Introduction
11.10.4 TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.10.5 TAGI Pharma Inc. Recent Development
11.11 Beijing Wellso Pharmaceutical Co
11.11.1 Beijing Wellso Pharmaceutical Co Company Details
11.11.2 Beijing Wellso Pharmaceutical Co Business Overview
11.11.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Introduction
11.11.4 Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.11.5 Beijing Wellso Pharmaceutical Co Recent Development
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Details
11.12.2 Glenmark Pharmaceuticals Business Overview
11.12.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
11.12.4 Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.12.5 Glenmark Pharmaceuticals Recent Development
11.13 Rusan Pharma Ltd
11.13.1 Rusan Pharma Ltd Company Details
11.13.2 Rusan Pharma Ltd Business Overview
11.13.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Introduction
11.13.4 Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.13.5 Rusan Pharma Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Naltrexone
1.2.3 Acamprosate
1.2.4 Disulfiram
1.2.5 Other
1.3 Market by Application
1.3.1 Global Medications for Alcohol Use Disorder (AUD) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Rehabilitation Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medications for Alcohol Use Disorder (AUD) Market Perspective (2021–2032)
2.2 Global Medications for Alcohol Use Disorder (AUD) Growth Trends by Region
2.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Medications for Alcohol Use Disorder (AUD) Historic Market Size by Region (2021–2026)
2.2.3 Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (2027–2032)
2.3 Medications for Alcohol Use Disorder (AUD) Market Dynamics
2.3.1 Medications for Alcohol Use Disorder (AUD) Industry Trends
2.3.2 Medications for Alcohol Use Disorder (AUD) Market Drivers
2.3.3 Medications for Alcohol Use Disorder (AUD) Market Challenges
2.3.4 Medications for Alcohol Use Disorder (AUD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medications for Alcohol Use Disorder (AUD) Players by Revenue
3.1.1 Global Top Medications for Alcohol Use Disorder (AUD) Players by Revenue (2021–2026)
3.1.2 Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Players (2021–2026)
3.2 Global Top Medications for Alcohol Use Disorder (AUD) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Medications for Alcohol Use Disorder (AUD) Revenue
3.4 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio
3.4.1 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medications for Alcohol Use Disorder (AUD) Revenue in 2025
3.5 Global Key Players of Medications for Alcohol Use Disorder (AUD) Head Offices and Areas Served
3.6 Global Key Players of Medications for Alcohol Use Disorder (AUD), Products and Applications
3.7 Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Type
4.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Type (2021–2026)
4.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (2027–2032)
5 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Application
5.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Application (2021–2026)
5.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
6.2 North America Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
6.4 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
7.2 Europe Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
7.4 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
8.2 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2021–2026)
8.4 Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
9.2 Latin America Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
9.4 Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size (2021–2032)
10.2 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2021–2026)
10.4 Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alkermes
11.1.1 Alkermes Company Details
11.1.2 Alkermes Business Overview
11.1.3 Alkermes Medications for Alcohol Use Disorder (AUD) Introduction
11.1.4 Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.1.5 Alkermes Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Introduction
11.2.4 Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.2.5 Merck KGaA Recent Development
11.3 Lundbeck
11.3.1 Lundbeck Company Details
11.3.2 Lundbeck Business Overview
11.3.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Introduction
11.3.4 Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.3.5 Lundbeck Recent Development
11.4 Alvogen
11.4.1 Alvogen Company Details
11.4.2 Alvogen Business Overview
11.4.3 Alvogen Medications for Alcohol Use Disorder (AUD) Introduction
11.4.4 Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.4.5 Alvogen Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Medications for Alcohol Use Disorder (AUD) Introduction
11.5.4 Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.5.5 Mylan Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Medications for Alcohol Use Disorder (AUD) Introduction
11.6.4 Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.6.5 Teva Recent Development
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Details
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Introduction
11.7.4 Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.7.5 Sun Pharmaceutical Industries Recent Development
11.8 Zydus Pharmaceuticals
11.8.1 Zydus Pharmaceuticals Company Details
11.8.2 Zydus Pharmaceuticals Business Overview
11.8.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
11.8.4 Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.8.5 Zydus Pharmaceuticals Recent Development
11.9 Taj Pharmaceuticals
11.9.1 Taj Pharmaceuticals Company Details
11.9.2 Taj Pharmaceuticals Business Overview
11.9.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
11.9.4 Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.9.5 Taj Pharmaceuticals Recent Development
11.10 TAGI Pharma Inc.
11.10.1 TAGI Pharma Inc. Company Details
11.10.2 TAGI Pharma Inc. Business Overview
11.10.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Introduction
11.10.4 TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.10.5 TAGI Pharma Inc. Recent Development
11.11 Beijing Wellso Pharmaceutical Co
11.11.1 Beijing Wellso Pharmaceutical Co Company Details
11.11.2 Beijing Wellso Pharmaceutical Co Business Overview
11.11.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Introduction
11.11.4 Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.11.5 Beijing Wellso Pharmaceutical Co Recent Development
11.12 Glenmark Pharmaceuticals
11.12.1 Glenmark Pharmaceuticals Company Details
11.12.2 Glenmark Pharmaceuticals Business Overview
11.12.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
11.12.4 Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.12.5 Glenmark Pharmaceuticals Recent Development
11.13 Rusan Pharma Ltd
11.13.1 Rusan Pharma Ltd Company Details
11.13.2 Rusan Pharma Ltd Business Overview
11.13.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Introduction
11.13.4 Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
11.13.5 Rusan Pharma Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Naltrexone
Table 3. Key Players of Acamprosate
Table 4. Key Players of Disulfiram
Table 5. Key Players of Other
Table 6. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million), 2021–2026
Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2021–2026)
Table 10. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2027–2032)
Table 12. Medications for Alcohol Use Disorder (AUD) Market Trends
Table 13. Medications for Alcohol Use Disorder (AUD) Market Drivers
Table 14. Medications for Alcohol Use Disorder (AUD) Market Challenges
Table 15. Medications for Alcohol Use Disorder (AUD) Market Restraints
Table 16. Global Medications for Alcohol Use Disorder (AUD) Revenue by Players (US$ Million), 2021–2026
Table 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players (2021–2026)
Table 18. Global Top Medications for Alcohol Use Disorder (AUD) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Medications for Alcohol Use Disorder (AUD) Revenue, 2025
Table 19. Ranking of Global Top Medications for Alcohol Use Disorder (AUD) Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Medications for Alcohol Use Disorder (AUD), Headquarters and Area Served
Table 22. Global Key Players of Medications for Alcohol Use Disorder (AUD), Products and Applications
Table 23. Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (US$ Million), 2021–2026
Table 26. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2021–2026)
Table 27. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2027–2032)
Table 29. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (US$ Million), 2021–2026
Table 30. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2021–2026)
Table 31. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2027–2032)
Table 33. North America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 35. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 48. Alkermes Company Details
Table 49. Alkermes Business Overview
Table 50. Alkermes Medications for Alcohol Use Disorder (AUD) Product
Table 51. Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 52. Alkermes Recent Development
Table 53. Merck KGaA Company Details
Table 54. Merck KGaA Business Overview
Table 55. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product
Table 56. Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 57. Merck KGaA Recent Development
Table 58. Lundbeck Company Details
Table 59. Lundbeck Business Overview
Table 60. Lundbeck Medications for Alcohol Use Disorder (AUD) Product
Table 61. Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 62. Lundbeck Recent Development
Table 63. Alvogen Company Details
Table 64. Alvogen Business Overview
Table 65. Alvogen Medications for Alcohol Use Disorder (AUD) Product
Table 66. Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 67. Alvogen Recent Development
Table 68. Mylan Company Details
Table 69. Mylan Business Overview
Table 70. Mylan Medications for Alcohol Use Disorder (AUD) Product
Table 71. Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 72. Mylan Recent Development
Table 73. Teva Company Details
Table 74. Teva Business Overview
Table 75. Teva Medications for Alcohol Use Disorder (AUD) Product
Table 76. Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 77. Teva Recent Development
Table 78. Sun Pharmaceutical Industries Company Details
Table 79. Sun Pharmaceutical Industries Business Overview
Table 80. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product
Table 81. Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 82. Sun Pharmaceutical Industries Recent Development
Table 83. Zydus Pharmaceuticals Company Details
Table 84. Zydus Pharmaceuticals Business Overview
Table 85. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product
Table 86. Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 87. Zydus Pharmaceuticals Recent Development
Table 88. Taj Pharmaceuticals Company Details
Table 89. Taj Pharmaceuticals Business Overview
Table 90. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product
Table 91. Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 92. Taj Pharmaceuticals Recent Development
Table 93. TAGI Pharma Inc. Company Details
Table 94. TAGI Pharma Inc. Business Overview
Table 95. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product
Table 96. TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 97. TAGI Pharma Inc. Recent Development
Table 98. Beijing Wellso Pharmaceutical Co Company Details
Table 99. Beijing Wellso Pharmaceutical Co Business Overview
Table 100. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product
Table 101. Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 102. Beijing Wellso Pharmaceutical Co Recent Development
Table 103. Glenmark Pharmaceuticals Company Details
Table 104. Glenmark Pharmaceuticals Business Overview
Table 105. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product
Table 106. Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 107. Glenmark Pharmaceuticals Recent Development
Table 108. Rusan Pharma Ltd Company Details
Table 109. Rusan Pharma Ltd Business Overview
Table 110. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product
Table 111. Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 112. Rusan Pharma Ltd Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Medications for Alcohol Use Disorder (AUD) Picture
Figure 2. Global Medications for Alcohol Use Disorder (AUD) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Medications for Alcohol Use Disorder (AUD) Market Share by Type: 2025 vs 2032
Figure 4. Naltrexone Features
Figure 5. Acamprosate Features
Figure 6. Disulfiram Features
Figure 7. Other Features
Figure 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Rehabilitation Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Medications for Alcohol Use Disorder (AUD) Report Years Considered
Figure 14. Global Medications for Alcohol Use Disorder (AUD) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Medications for Alcohol Use Disorder (AUD) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region: 2025 vs 2032
Figure 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players in 2025
Figure 18. Global Medications for Alcohol Use Disorder (AUD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue in 2025
Figure 20. North America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 22. United States Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 26. Germany Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Share by Region (2021–2032)
Figure 34. China Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 42. Mexico Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 46. Israel Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Alkermes Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 50. Merck KGaA Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 51. Lundbeck Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 52. Alvogen Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 53. Mylan Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 54. Teva Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 55. Sun Pharmaceutical Industries Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 56. Zydus Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 57. Taj Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 58. TAGI Pharma Inc. Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 59. Beijing Wellso Pharmaceutical Co Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 60. Glenmark Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 61. Rusan Pharma Ltd Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Naltrexone
Table 3. Key Players of Acamprosate
Table 4. Key Players of Disulfiram
Table 5. Key Players of Other
Table 6. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million), 2021–2026
Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2021–2026)
Table 10. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2027–2032)
Table 12. Medications for Alcohol Use Disorder (AUD) Market Trends
Table 13. Medications for Alcohol Use Disorder (AUD) Market Drivers
Table 14. Medications for Alcohol Use Disorder (AUD) Market Challenges
Table 15. Medications for Alcohol Use Disorder (AUD) Market Restraints
Table 16. Global Medications for Alcohol Use Disorder (AUD) Revenue by Players (US$ Million), 2021–2026
Table 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players (2021–2026)
Table 18. Global Top Medications for Alcohol Use Disorder (AUD) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Medications for Alcohol Use Disorder (AUD) Revenue, 2025
Table 19. Ranking of Global Top Medications for Alcohol Use Disorder (AUD) Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Medications for Alcohol Use Disorder (AUD), Headquarters and Area Served
Table 22. Global Key Players of Medications for Alcohol Use Disorder (AUD), Products and Applications
Table 23. Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (US$ Million), 2021–2026
Table 26. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2021–2026)
Table 27. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2027–2032)
Table 29. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (US$ Million), 2021–2026
Table 30. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2021–2026)
Table 31. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2027–2032)
Table 33. North America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 35. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size by Country (US$ Million), 2027–2032
Table 48. Alkermes Company Details
Table 49. Alkermes Business Overview
Table 50. Alkermes Medications for Alcohol Use Disorder (AUD) Product
Table 51. Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 52. Alkermes Recent Development
Table 53. Merck KGaA Company Details
Table 54. Merck KGaA Business Overview
Table 55. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product
Table 56. Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 57. Merck KGaA Recent Development
Table 58. Lundbeck Company Details
Table 59. Lundbeck Business Overview
Table 60. Lundbeck Medications for Alcohol Use Disorder (AUD) Product
Table 61. Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 62. Lundbeck Recent Development
Table 63. Alvogen Company Details
Table 64. Alvogen Business Overview
Table 65. Alvogen Medications for Alcohol Use Disorder (AUD) Product
Table 66. Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 67. Alvogen Recent Development
Table 68. Mylan Company Details
Table 69. Mylan Business Overview
Table 70. Mylan Medications for Alcohol Use Disorder (AUD) Product
Table 71. Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 72. Mylan Recent Development
Table 73. Teva Company Details
Table 74. Teva Business Overview
Table 75. Teva Medications for Alcohol Use Disorder (AUD) Product
Table 76. Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 77. Teva Recent Development
Table 78. Sun Pharmaceutical Industries Company Details
Table 79. Sun Pharmaceutical Industries Business Overview
Table 80. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product
Table 81. Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 82. Sun Pharmaceutical Industries Recent Development
Table 83. Zydus Pharmaceuticals Company Details
Table 84. Zydus Pharmaceuticals Business Overview
Table 85. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product
Table 86. Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 87. Zydus Pharmaceuticals Recent Development
Table 88. Taj Pharmaceuticals Company Details
Table 89. Taj Pharmaceuticals Business Overview
Table 90. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product
Table 91. Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 92. Taj Pharmaceuticals Recent Development
Table 93. TAGI Pharma Inc. Company Details
Table 94. TAGI Pharma Inc. Business Overview
Table 95. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product
Table 96. TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 97. TAGI Pharma Inc. Recent Development
Table 98. Beijing Wellso Pharmaceutical Co Company Details
Table 99. Beijing Wellso Pharmaceutical Co Business Overview
Table 100. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product
Table 101. Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 102. Beijing Wellso Pharmaceutical Co Recent Development
Table 103. Glenmark Pharmaceuticals Company Details
Table 104. Glenmark Pharmaceuticals Business Overview
Table 105. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product
Table 106. Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 107. Glenmark Pharmaceuticals Recent Development
Table 108. Rusan Pharma Ltd Company Details
Table 109. Rusan Pharma Ltd Business Overview
Table 110. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product
Table 111. Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (US$ Million), 2021–2026
Table 112. Rusan Pharma Ltd Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Medications for Alcohol Use Disorder (AUD) Picture
Figure 2. Global Medications for Alcohol Use Disorder (AUD) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Medications for Alcohol Use Disorder (AUD) Market Share by Type: 2025 vs 2032
Figure 4. Naltrexone Features
Figure 5. Acamprosate Features
Figure 6. Disulfiram Features
Figure 7. Other Features
Figure 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Application: 2025 vs 2032
Figure 10. Hospital Case Studies
Figure 11. Rehabilitation Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Medications for Alcohol Use Disorder (AUD) Report Years Considered
Figure 14. Global Medications for Alcohol Use Disorder (AUD) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Medications for Alcohol Use Disorder (AUD) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region: 2025 vs 2032
Figure 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players in 2025
Figure 18. Global Medications for Alcohol Use Disorder (AUD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue in 2025
Figure 20. North America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 22. United States Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 26. Germany Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Medications for Alcohol Use Disorder (AUD) Market Share by Region (2021–2032)
Figure 34. China Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 42. Mexico Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Medications for Alcohol Use Disorder (AUD) Market Share by Country (2021–2032)
Figure 46. Israel Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Alkermes Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 50. Merck KGaA Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 51. Lundbeck Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 52. Alvogen Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 53. Mylan Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 54. Teva Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 55. Sun Pharmaceutical Industries Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 56. Zydus Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 57. Taj Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 58. TAGI Pharma Inc. Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 59. Beijing Wellso Pharmaceutical Co Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 60. Glenmark Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 61. Rusan Pharma Ltd Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232